Cargando…

Atypical Antipsychotic Lumateperone Effects on the Adrenal Gland With Possible Beneficial Effect of Quercetin Co-administration

Schizophrenia remains one of the most chronic and highly disabling mental disorders. Lumateperone is a recent FDA-approved atypical antipsychotic drug for the treatment of schizophrenia. However, the internal FDA pathologist raised concerns regarding pigment deposition associated with degeneration i...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Haroun, Hala, Ewida, Suzy Fayez, Mohamed, Wael M. Y., Bashandy, Manar Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279776/ https://www.ncbi.nlm.nih.gov/pubmed/34276400 http://dx.doi.org/10.3389/fphys.2021.674550

Ejemplares similares

Newer antipsychotics: Brexpiprazole, cariprazine, and lumateperone: A pledge or another unkept promise?
por: Barman, Rajdip, et al.
Publicado: (2021)

The role of lumateperone in the treatment of schizophrenia
por: Syed, Alveena Batool, et al.
Publicado: (2021)

Illuminating Hope for Mental Health: A Drug Review on Lumateperone
por: Tarzian, Martin, et al.
Publicado: (2023)

The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity
por: Zhao, Yueshui, et al.
Publicado: (2017)

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial
por: Correll, Christoph U., et al.
Publicado: (2020)

New synthesis of a late-stage tetracyclic key intermediate of lumateperone
por: Milen, Mátyás, et al.
Publicado: (2022)

Management of subjects with Intermittent Explosive Disorder and Autism Spectrum Disorder with Lumateperone
por: Mehdiratta, N., et al.
Publicado: (2023)

Atypical dissemination of lung cancer to the adrenal gland and to the spleen
por: Chorąży, Marek, et al.
Publicado: (2012)

Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity
por: Sato, Shin, et al.
Publicado: (2020)

F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA
por: Davis, Robert, et al.
Publicado: (2018)

Predictors of Effect of Atypical Antipsychotics on Speech
por: Sinha, Preeti, et al.
Publicado: (2015)

M205. LONG-TERM SAFETY OF LUMATEPERONE (ITI-007): METABOLIC EFFECTS IN A 1-YEAR STUDY
por: Satlin, Andrew, et al.
Publicado: (2020)

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
por: Lymperopoulos, Anastasios, et al.
Publicado: (2021)

Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
por: Alvarez-Herrera, Samantha, et al.
Publicado: (2020)

Seborrheic Dermatitis: A Case of an Atypical Side Effect of Atypical Antipsychotics
por: Bishay, Ramy, et al.
Publicado: (2023)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Beneficial Effects of Quercetin on Microcystin-LR Induced Tight Junction Defects
por: Zhou, Yuan, et al.
Publicado: (2021)

Beneficial Effect of Quercetin on Erythrocyte Properties in Type 2 Diabetic Rats
por: Jasenovec, Tomas, et al.
Publicado: (2021)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

The effect of recumbency position on the ultrasound measurement of the canine adrenal gland in non-adrenal gland illness
por: Rose, Anne Marie, et al.
Publicado: (2017)

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
por: Torrent, Carla, et al.
Publicado: (2010)

Effect of Atypical Antipsychotics on Fetal Growth: Is the Placenta Involved?
por: Raha, Sandeep, et al.
Publicado: (2012)

T205. LUMATEPERONE IN THE TREATMENT OF SCHIZOPHRENIA: EVALUATION OF EXTRAPYRAMIDAL AND MOTOR SYMPTOMS IN 4 LATE-PHASE CLINICAL TRIALS
por: Durgam, Suresh, et al.
Publicado: (2020)

Lumateperone Normalizes Pathological Levels of Acute Inflammation through Important Pathways Known to Be Involved in Mood Regulation
por: Dutheil, Sophie, et al.
Publicado: (2023)

Voluminous Incidental Oncocytic Neoplasm of the Adrenal Gland With Uncertain Malignant Potential
por: Chakroun, Marouene, et al.
Publicado: (2016)

Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics
por: Al-Aojan, S., et al.
Publicado: (2018)

Effect of atypical antipsychotics on body weight in geriatric psychiatric inpatients
por: Yeung, Eugene YH, et al.
Publicado: (2017)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY
por: Vanover, Kimberly, et al.
Publicado: (2018)

Dopamine D(2) receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia
por: Vanover, Kimberly E., et al.
Publicado: (2018)

Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials
por: Kane, John M, et al.
Publicado: (2021)

Atypical imaging features of adrenal gland lesions in children – report of three cases and review of literature
por: Czerwińska, Katarzyna, et al.
Publicado: (2012)

Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
por: Vallée, Alexandre, et al.
Publicado: (2021)

Disease of Adrenal Glands
por: Iacobellis, Gianluca, et al.
Publicado: (2015)

Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans
por: Gubert, Priscila, et al.
Publicado: (2013)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
por: Khasawneh, Fadi T., et al.
Publicado: (2014)

Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics
por: Maher, Alicia R., et al.
Publicado: (2012)

Tumors of the adrenal gland and extra-adrenal paraganglia
por: Lack, Ernest E.
Publicado: (1997)

Atypical antipsychotics and delirium in critical care
por: Wise, Matt P, et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sksob4tuft7o4rdqrvnq8lsq2e